About Sanorapharma
Sanorapharma is a Healthcare company based in India. Sanora Pharmaceuticals offers affordable, innovative drugs for primary care worldwide. It operates on a B2B model. The company has 13 employees. Its Indian entity Sanora Pharmaceuticals Private Limited reported revenue of ₹6.77 Cr. Sanorapharma offers products and services including Sogcillin CV 625, Sogpodox SP, Bact, and Panedge DSR. Its focus areas include Pharmaceuticals, Primary Care and Essential Drugs.
Company details
Sanora Pharmaceuticals, based in Mumbai, India, produces and supplies essential pharmaceutical drugs focused on primary care needs. Established in 2011 and incorporated in 2017, it emphasizes cost-effective, innovative products for global accessibility. The company partners with entities to deliver high-quality medications, improving patient health through research and distribution efforts.
- Headquarters India
- Employees 13
- SectorsHealthcare
- Email••••••••
- Website sanorapharma.in
- Legal Name Sanora Pharmaceuticals Private Limited
- Date of Incorporation 15 Dec, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹6.77 Cr
FY 2025 · +39% YoY
- Net Profit₹55.5 Lakh
FY 2025 · 8% margin
- EBITDA₹75.5 Lakh
FY 2025 · 11% margin
- Employee Count13
Associated legal entities of Sanorapharma
Sanorapharma operates through Sanora Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sanora Pharmaceuticals Private Limited CIN U24304MH2017PTC302917 | Active | 15 Dec 2017 | Mumbai, Maharashtra | ₹6.8 Cr | 13 | 2 | View details |
Products & Services of Sanorapharma
Sanorapharma offers a comprehensive portfolio of products and services, including Sogcillin CV 625, Sogpodox SP, Bact, and Panedge DSR.
Antibiotic for treating bacterial infections effectively.
Drug for managing various infections with high efficacy.
Provides treatment for bacterial ailments promptly.
Medication for digestive issues and related conditions.
Board of directors of Sanora Pharmaceuticals Private Limited (Sanorapharma)
Sanora Pharmaceuticals Private Limited is the primary company behind Sanorapharma. The board of Sanora Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Dinesh Krishnan, appointed in 2025. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dinesh Krishnan DIN 11196133 | Director | 16 Jul 2025 | 1 yr 3 mo | Sanora Pharmaceuticals Private Limited |
| Ajithkumar Nedumpilly Anandan DIN 11196054 | Director | 16 Jul 2025 | 1 yr 3 mo | Sanora Pharmaceuticals Private Limited |
Financials of Sanorapharma
Figures of Sanora Pharmaceuticals Private Limited, the primary company behind Sanorapharma, for FY 2025. Revenue was ₹6.77 Cr (+39% year on year). Net profit was ₹55.5 Lakh (8% margin). EBITDA was ₹75.5 Lakh (11% margin). Revenue has grown at a compounded annual rate of +33% over three years and +36% over five years.
- ₹6.77 CrRevenue · FY 2025 · +39% YoY
- ₹55.5 LakhNet profit · 8% margin
- ₹75.5 LakhEBITDA · 11% margin
- ₹12.7 LakhPaid-up capital
- 13Employees (provident fund records)
- +33%Revenue CAGR, 3 years
- +36%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sanora Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Sanorapharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Sanorapharma
The website of Sanorapharma (sanorapharma.in) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 108.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sanorapharma
Sanorapharma is headquartered in India.
Sanorapharma has 13 employees.
The primary company behind Sanorapharma, Sanora Pharmaceuticals Private Limited, reported revenue of ₹6.77 Cr for FY 2025, up 39% year on year.
Sanora Pharmaceuticals, based in Mumbai, India, produces and supplies essential pharmaceutical drugs focused on primary care needs. Established in 2011 and incorporated in 2017, it emphasizes cost-effective, innovative products for global accessibility. The company partners with entities to deliver high-quality medications, improving patient health through research and distribution efforts.
Sanorapharma offers Sogcillin CV 625, Sogpodox SP, Bact, and Panedge DSR.
Sanorapharma operates through Sanora Pharmaceuticals Private Limited.
The legal entities of Sanorapharma currently have 2 directors, including Dinesh Krishnan, Ajithkumar Nedumpilly Anandan.